IN2014CN01009A - - Google Patents

Info

Publication number
IN2014CN01009A
IN2014CN01009A IN1009CHN2014A IN2014CN01009A IN 2014CN01009 A IN2014CN01009 A IN 2014CN01009A IN 1009CHN2014 A IN1009CHN2014 A IN 1009CHN2014A IN 2014CN01009 A IN2014CN01009 A IN 2014CN01009A
Authority
IN
India
Prior art keywords
imatinib
pharmaceutical formulations
salts
relate
aspects
Prior art date
Application number
Other languages
English (en)
Inventor
Suresh Konatham
Madhusudan Malladi
Prasad Vure
Moumita Biswas
Rahul Bhise
Ramesh Kota
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Priority to IN1009CHN2014 priority Critical patent/IN2014CN01009A/en
Priority claimed from PCT/IN2012/000488 external-priority patent/WO2013008253A2/fr
Publication of IN2014CN01009A publication Critical patent/IN2014CN01009A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1009CHN2014 2011-07-11 2012-07-11 IN2014CN01009A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1009CHN2014 IN2014CN01009A (fr) 2011-07-11 2012-07-11

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161506191P 2011-07-11 2011-07-11
PCT/IN2012/000488 WO2013008253A2 (fr) 2011-07-11 2012-07-11 Formulations d'imatinib
IN1009CHN2014 IN2014CN01009A (fr) 2011-07-11 2012-07-11

Publications (1)

Publication Number Publication Date
IN2014CN01009A true IN2014CN01009A (fr) 2015-04-10

Family

ID=54395824

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1009CHN2014 IN2014CN01009A (fr) 2011-07-11 2012-07-11

Country Status (1)

Country Link
IN (1) IN2014CN01009A (fr)

Similar Documents

Publication Publication Date Title
PH12018500960A1 (en) Processes for preparing isoquinolinones and solid forms of isoquinolinones
IN2014MN02598A (fr)
MY194087A (en) Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
HK1196849A1 (en) Recombinant microorganism for the production of useful metabolites
WO2012103226A3 (fr) Formulations de bendamustine
MX2016006336A (es) Compuestos pirazolopirimidina.
MY163083A (en) Solid forms of a pharmaceutically active substance
IN2014MN02652A (fr)
IN2014MN02657A (fr)
IN2015DN00185A (fr)
IN2015DN01119A (fr)
WO2013098833A3 (fr) Procédés et intermédiaires destinés à la préparation de rivaroxaban
CR20150114A (es) Composición farmacéutica recubierta que contiene regorafenib
WO2014041565A3 (fr) Procédé amélioré pour la préparation de vilantérol et de ses intermédiaires
IN2015DN00845A (fr)
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
JO3742B1 (ar) مركب بيرانو داي بيريدين
MX2016009621A (es) Derivados de fur0-3-carboxamida y metodos de uso.
WO2013008253A3 (fr) Formulations d'imatinib
IN2013MU00665A (fr)
UY35183A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
MX2016013561A (es) Activadores de herg policiclicos.
IN2014DN08296A (fr)
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.